Solifenacin succinate
98%
- Product Code: 53241
CAS:
242478-38-2
Molecular Weight: | 480.55 g./mol | Molecular Formula: | C₂₇H₃₂N₂O₆ |
---|---|---|---|
EC Number: | MDL Number: | MFCD09952287 | |
Melting Point: | 114-124°C | Boiling Point: | 505.5°C |
Density: | Storage Condition: | room temperature, dry |
Product Description:
Solifenacin succinate is primarily used in the treatment of overactive bladder (OAB) syndrome. It helps alleviate symptoms such as frequent urination, urgency, and urinary incontinence by relaxing the bladder muscles. This medication is often prescribed to patients who experience these symptoms due to involuntary bladder contractions. It improves the bladder's capacity to store urine, reducing the need for frequent bathroom visits. Additionally, it can enhance the quality of life for individuals suffering from OAB by providing better control over bladder function. It is typically administered orally in tablet form and is part of a broader treatment plan that may include lifestyle changes and behavioral therapies.
Product Specification:
Test | Specification |
---|---|
APPEARANCE | White to Almost white powder to crystal |
PURITY | 97.5-100 |
MELTING POINT | 145.0-149.0 |
Infrared spectrum | Conforms to Structure |
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
0.250 | 10-20 days | ฿2,380.00 |
+
-
|
1.000 | 10-20 days | ฿6,980.00 |
+
-
|
Solifenacin succinate
Solifenacin succinate is primarily used in the treatment of overactive bladder (OAB) syndrome. It helps alleviate symptoms such as frequent urination, urgency, and urinary incontinence by relaxing the bladder muscles. This medication is often prescribed to patients who experience these symptoms due to involuntary bladder contractions. It improves the bladder's capacity to store urine, reducing the need for frequent bathroom visits. Additionally, it can enhance the quality of life for individuals suffering from OAB by providing better control over bladder function. It is typically administered orally in tablet form and is part of a broader treatment plan that may include lifestyle changes and behavioral therapies.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :